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Stenting of central venous stenoses in hemodialysis patients: Long-
term results. From November 1992 through July 1996, 15 Wallstents
were implanted for the treatment of symptomatic central arm vein
obstructions in 14 hemodialysis patients (10 subclavian, 2 brachiocephalic
vein stenoses, 2 subclavian vein occlusions). There were no acute compli-
cations. Al! patients were investigated by clinical examination and color-
duplex sonography at regular three month intervals. When recurrent
swelling predicted restenosis, phlebography was also performed. During
the follow-up, high grade stenoses at the central or peripheral ends of four
stents were successfully treated with five overlapping stents, giving a total
of 20 Wallstent' implantations. Complete occlusion of another subclavian
vein distally to the stent at 16 months required ligation of the patient's
arteriovenous fistula. Life table analysis including all 20 stents revealed a
cumulative primary one year (two year) stent patency of 70% (50%). The
cumulative secondary one year (two year) stent patency was 100% (85%).
We believe that in hemodialysis patients, PTA plus Walistent" implanta-
tion is a safe and effective procedure in the treatment of central venous
stenoses and even short occlusions. Consequent follow-up allows for
timely diagnosis and treatment of restenoses, thus guaranteeing long-term
patency rates comparable to those of veno-venous bypass surgery.
Stenoses and occlusions of central arm veins frequently occur
after repeated or prolonged catheterization for hemodialysis
access [1, 2], especially, if the subclavian vein was used for access
[3], and following catheter-associated infection [4]. If the draining
vein of a functioning shunt is obstructed, extreme venous hyper-
tension with pain, incapacitating swelling, and ulceration may
occur [5, 6]. Surgical treatment (patch angioplasty or bypass
procedures) may be hazardous in these often multimorbid pa-
tients [7, 8]. Percutaneous dilation (PTA) is less invasive, however,
the long-term results are disappointing [9—12]. We therefore
combined PTA with implantation of flexible, self-expanding stents
(PTA+S).
Methods
From November 1992 through July 1996, 15 Wallstents"' were
implanted for treatment of symptomatic central arm vein obstruc-
tions in 14 hemodialysis patients (10 suhclavian, 2 brachiocephalie
vein stenoses, 2 subclavian vein occlusions). All patients had a
history of repeated or prolonged subclavian vein catheterization
for hemodialysis access. All obstructions were central to a func-
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tioning access fistula which had been created two months to seven
years prior to onset of symptoms. Eleven patients presented with
massive arm swelling, two suffered from additional unilateral face
swelling, and the last had arm swelling and localized graft
infection. All patients had chronic obstructions. Symptoms had
lasted for two months to two years before treatment. In one
patient, an unsuccessful PTA at another institution had preceded
stenting by four weeks.
Venous pathology was visualized by transhrachial fine needle-
arteriovenography in DSA technique (Fig. 1A) immediately be-
fore intervention. Then all patients received 5000 IU heparin i.v.
All stents were placed via a transfemoral route to avoid unneces-
sary trauma to peripheral arm veins. Guide wire passing of tight,
kinking stenoses, however, sometimes had to be facilitated by
rendezvous maneuvers with additional upper arm access. Two
short occlusions were reopened with rotating devices (Rotacs'
catheter, Fig. 1B) [13]. Only extremely tight stenoses were pre-
dilated to allow for passage of the stent equipment. After place-
ment all stents had to be dilated with high-pressure balloons to
achieve complete opening within the fibrotic venous strictures
(Fig. 1C). Over-dilation of adjacent vein segments was strictly
avoided. After stenting a PYT of 60 seconds to 90 seconds was
maintained for three days by a continuous heparin infusion.
Patients were advised to take 100 mg acetylsalicylic acid a day
throughout the study period.
All patients were investigated by clinical examination and
color-duplex sonography at regular three month intervals. When
recurrent swelling predicted symptomatic restenosis, phlebogra-
phy was also done. Whenever indicated interventional redo
procedures were performed giving a total of 20 Wallstent''
implantations. Cumulative primary and secondary patency rates
including all 20 stents were estimated by life table analysis [14]
according to the recommendations of the International Consensus
Committee on Chronic Venous Disease [15].
Results
Stent placement with complete opening was achieved in all
cases. Besides local pain during dilation and minor hematomas at
puncture sites, there were no procedure-related complications,
not even during the Rotacs"' maneuvers. All patients were
completely free of symptoms within 24 to 48 hours after treat-
ment. Arteriovenous (av) fistulae and grafts were used for hemo-
dialysis after the procedure when indicated. There were no signs
or symptoms of shunt dysfunction or recirculation. The localized
•1; •
recurred in five patients (with 6 stents) after 3, 6, 7, 10, and 16
months, respectively.
Complete visualization by color-duplex sonography was possi-
ble in only 10 of 20 stents. In these patients, repeat investigations
during the study period revealed only a smooth neo-intima with
no areas of stenosis within the stents. In three patients out of five
with recurrent swelling, however, venous obstructions (2 high
grade stenoses, I complete occlusion) were detected in peripheral
vein segments adjacent to the widely patent stents. Phlebography
was done in all five patients with recurring complaints. Ultrasound
findings were confirmed in the three cases with complete sono-
graphic visualization of the stents. In two additional patients their
very central stents could not completely be examined by sonogra-
phy for anatomical reasons. These stents were also widely patent.
Stenoses were located in vein segments close to the central ends
of the stents.
High grade stenoses at the central or peripheral ends of four
stents were successfully treated with five overlapping stents.
Complete occlusion of a subclavian vein distally to the stent at 16
months required ligation of the patient's av-fistula after unsuc-
cessful interventional treatment. Life table analysis of all 20
Wallstents implanted so far (Fig. 2) gave a cumulative primary
one year (two year) stcnt patency of 70% (50%). Cumulative
secondary one year (two year) patency was 100% (85%).
Comment
C
Fig. 1. A. Complete occlusion of left subclavian vein 18 months after
creation of proximal cimino-fistula. Extensive collaterals around left shoul-
der and left upper thoracic aperture owing to functioning av-fistula.
Guidewire already passed the occlussion. B. Transbracial RotacsTM ma-
neuver necessary to allow for introduction of balloon catheter. C. Collat-
erals vanish immediatley after successful PTA and WallstentTM implanta-
tion.
graft infection healed after excision of the infected prosthetic
segment.
Four patients died (3 from complications of their coronary
artery disease, 1 from unexplained scpticemia) after 7, 8, 15 and
24 months, respectively, with patent stents. All other patients
could be followed up during the whole study period (from 1
month to 3 years, median 9 months). Arm or face swelling
Typical clinical findings in subclavian vein obstruction are arm
swelling and development of widespread subcutaneous venous
collaterals around the shoulder and the upper thoracic aperture.
Especially when the draining vein of a functioning av-fistula is
stenosed, massive venous hypertension with pain and peripheral
ulceration may develop [1, 2, 5]. Strictures of the central subcla-
vian or inriominate vein may cause additional unilateral swelling
of breast, face, and neck [16].
Before treatment exact delineation of venous pathology is
indispensable. For this indication, color-duplex ultrasound is of
limited value, because neither the innominate vein nor the
proximal third of the subclavian vein can be visualized with this
technique [17]. Phlebography is still felt to be the gold standard
for diagnosis of upper extremity venous stenoses and occlusions
[15]. In our study, sonographic pre-treatment localization of
central venous strictures was not attempted. Color-coded ultra-
sound was used for follow-up examinations of stented vein
segments. Only half of the stents could be completely visualized,
and only three out of five restenoses were seen. In these few cases,
sonographic findings were completely confirmed by arteriovenog-
raphy. The other stents and restenoses were at least in part
located deep in the mediastinal part of the subclavian and
innominate veins beyond ultrasound accessibility. In these pa-
tients clinical diagnosis of restenosis was based solely on recurrent
arm (and face) swelling, and was also confirmed by arteriovenog-
raphy. Transbrachial fine needle-arteriovenography in DSA tech-
nique always allowed an exact delineation of the site and exten-
sion of all obstructions as well as of important collaterals.
Therefore, interventional therapy could immediately follow a
radiological diagnosis.
There are several options for the treatment of venous hyper-
tension due to outflow obstruction of functioning hemodialysis
access. Fistula ligation [5, 6] is the least invasive as well as the
most frustrating operation, as the vascular pathology causing the
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Fig. 2. Cumulative primaly (LI) and sccondaiy
___________________________________________________________________________________ • patency of central venous stents in
0 3 6 9 12 15 18 21 24 hemodialysis patients. Symbol I representsstandard deviations.
Table 1. Primary one and two year patency rates of PTA, PTA +
Wallstent rS, implantation, and surgery for central venous stenoses in
hemodialysis patients
Author Patient 12 24
________
[Referencel # Months Months
PTA Glanz, 1987 [9] 30 35% 10%
Wisselink, 1993 [12] 15 36% 0%
Quinn, 1995 [281 10 12%
Money, 1995 [281 26 7%
PTA + Wallstent" Shoenfeld, 1994 [30] 19 68%
Money, 1995 [281 13 71%
Vorwerk, 1995 [29] 27 60% 60%
Mickley, 1996 14 70% 50%
Surgery Wisselink, 1993 [12] 13 86% 66%
______
Money, 1995 [28] 13 80%
Some of the stenoses in this study were treated with Palmaz stents
patients problem is not corrected. The respective extremity is thus
rendered unsuitable for further shunt operations. Patch angio-
plasty of a subclavian or innominate vein as well as orthotopic
bypass surgery [7, 8] makes clavicular or sternal osteotomy (and
general anesthesia) necessary and is therefore burdened with
significant morbidity and even mortality in these chronically ill
and often rnultimorbid patients. Extra-anatomical bypass (such as
subclavian-to-jugular [18, 19]) is less distressing to the patient;
however, another central vein is lost for further access. In
consequence, non-operative, interveritional procedures that are
appropriate to obtain and maintain central venous patency in
hemodialysis patients have been investigated.
Most of the patients present with long lasting symptoms sub-
stantiating the chronic nature of their stenoses and occlusions.
Therefore, thrombectomy, thrombaspiration, or thrombolysis
alone are not likely to sufficiently restore venous patency. In
selected cases with evidence of fresh thrombi causing total
obstruction of a former fihiforme venous stricture, however,
thrombolysis may help to re-establish the stenosed lumen to allow
for additional PTA [201. PTA of central venous stenoses in
hemodialysis patients has been reported since the early 1980s [9,
11, 21—23]. Because of frequent restenoses arid occlusions, how-
ever, one year primary patency of PTA alone is less than 40%
(Table 1). To reduce the number of reintervcntions, stent implan-
tation was added to PTA by different investigators [24—271.
L.ong-term results after implantation of Gianturco stents into
central veins of hemodialysis patients are not better than PTA
[10]. The self-expandable Wallsten(' [28, 29] and the balloon-
expandable Palmaz stent [30], however, have recently been re-
ported to allow for primary one year (two year) patency rates of
60% to 71% (60%) thus almost resembling the results after
surgical correction [12, 28] of central venous stenoses (Table 1).
After demonstrating the favorable results of PTA+S when
compared to PTA alone for postoperative central venous stric-
tures [24], we started this prospective study in hemodialysis
patients. Ten subclavian and two innominate vein stenoses and
two subclavian vein occlusions were treated by immediate Wall-
stent implantation. Only in one patient, stenting was performed
four weeks after unsuccessful PTA at another institution. During
the study period, another four patients with central venous
occlusions were operated on. Three of them presented with long
subclavian vein occlusions that could not be recanalized percuta-
neously. In these cases an extra-anatomical axillary-to-internal
jugular vein bypass graft was implanted. In the fourth patient,
bilateral subclavian vein and superior vena caval occlusion re-
quired construction of a subclavian artery-to-right atrial access
graft [31].
Our results confirm the earlier communications quoted above.
The Wallstent has some mechanical advantages over alternative
stent models that should be mentioned. It is flexible even when
constrained on the delivery catheter, so that it can safely be used
in a tortuous stenosis once a guide wire has been properly
positioned. During placement the stent will attach closely to the
vessel wall by its own elasticity thus preventing later dislocation.
The large but unpredictable extent of stent shortening during
delivery, however, may cause some difficulty with respect to the
exact positioning of the proximal end of the Wallstent'. Innom-
mate vein stenoses close to the confluence therefore should be
stented via an upper extremity venous approach. If cannulation of
an arm vein has to be avoided in order not to further compromise
the outflow tract of a functioning hemodialysis access, transfemo-
ral implantation of a Palmaz stent should he considered [30].
During stent implantation patients were anticoagulated with
heparin. From the first post-interventional day on, they were
advised to take 100 mg acetylsalicylic acid a day. The same
medication has been recommended by others [29]. However,
there are no reliable data on the possible value of acetylsalicylic
acid or of vitamin K-antagonists to maintain long-term patency of
central venous stents, as comparative studies are lacking.
In hemodialysis patients, PTA plus Wallstenr implantation is
a safe and effective procedure in the treatment of central venous
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for timely diagnosis and treatment of restenoses thus guarantee-
ing long-term patency rates comparable to those of surgery.
Veno-venous bypass implantation should therefore be restricted
to long venous occlusions.
Reprint requests to Volker Mickley, M.D., Department of Thoracic and
Vascular Surgety, University of Ulm, Steinhoeveistr. 9, D-89075 Vim, Ger-
many.
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